The manufacturing of medicinal products is for us not only a matter of implementing a certain technological process, but a human mission based on high standards of quality, safety and efficacy of medications
Sofia, Bulgaria, August 21, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 20, 2025 the Company sold 68 049 (sixty-eight thousand and forty-nine) treasury shares representing 0.01% of the share capital of the Company, at a total value of BGN 166 787.20 on the Bulgarian Stock Exchange, the average price per share was BGN 2.45.
Sofia, Bulgaria, August 20, 2025 – According to the requirements of Art. 100t of the Law on Public Offering of Securities (LPOS), “Sopharma” AD (SFA: “Bulgarian Stock Exchange” AD, SPH: Warsaw Stock Exchange) notifies, that for July 2025 the Company recorded decrease in sales of 23% compared to the same month of the previous year, incl. 25% decrease in domestic sales and 22% decrease in export sales.
For the period from the beginning of 2025, the Company realized a 4% increase in sales, including 6% decrease in domestic sales and a 12% increase in export sales.
Sofia, Bulgaria, August 20, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 19, 2025 the Company sold 3 900 (three thousand nine hundred) treasury shares representing 0.001% of the share capital of the Company, at a total value of BGN 9 603.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.46.
Sofia, Bulgaria, August 19, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 18, 2025 the Company sold 1 100 (one thousand one hundred) treasury shares representing 0.0002% of the share capital of the Company, at a total value of BGN 2 707.00 on the Bulgarian Stock Exchange, the average price per share was BGN 2.46.
Sofia, Bulgaria, August 18, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on August 15, 2025 the Company sold 333 272 (three hundred thirty three thousand two hundred and seventy two) treasury shares representing 0.06% of the share capital of the Company, at a total value of BGN 803 834.80 on the Bulgarian Stock Exchange, the average price per share was BGN 2.41.
